Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-031857
Filing Date
2022-05-25
Accepted
2022-05-25 16:18:24
Documents
1
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3967
  Complete submission text file 0001209191-22-031857.txt   5511
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY SAN FRANCISCO CA 94083
Business Address
MORRISSEY MICHAEL (Reporting) CIK: 0001202096 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40407 | Film No.: 22963137

Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Issuer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations